Company Alkem Laboratories Limited

Equities

ALKEM

INE540L01014

Pharmaceuticals

Market Closed - NSE India S.E. 07:40:29 2024-04-24 am EDT 5-day change 1st Jan Change
4,721 INR +0.35% Intraday chart for Alkem Laboratories Limited -0.28% -9.26%

Business Summary

Alkem Laboratories Limited is an India-based company, which is engaged in the pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company offers its products across various therapeutic areas, such as Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, and Vitamins, Mineral and Nutrition. Its product range includes Rx Products, Alkem Generics and OTC Product. The Company’s product portfolio includes brands, such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The Company operates through a segment, Pharmaceuticals. It has approximately 21 manufacturing facilities at multiple locations in India and the United States. The Company has approximately 800 brands and operates in 40 countries.

Number of employees: 16,871

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical and Related Products
100.0 %
106,342 100.0 % 115,993 100.0 % +9.08%

Sales per region

INR in Million2022Weight2023Weight Delta
India
70.3 %
75,266 70.8 % 81,600 70.3 % +8.41%
United States
21.7 %
23,291 21.9 % 25,134 21.7 % +7.91%
Other Countries
8.0 %
7,785 7.3 % 9,259 8.0 % +18.94%

Managers

Managers TitleAgeSince
Chief Executive Officer - 23-09-21
Director of Finance/CFO - Jan. 31
Compliance Officer 54 06-10-31
Director/Board Member 41 13-08-08
Investor Relations Contact - -
Corporate Officer/Principal - 07-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 15-03-15
Chief Executive Officer 84 73-08-07
Director/Board Member 68 15-06-28
Director/Board Member 41 13-08-08
Director/Board Member 61 87-12-31
Director/Board Member - 11-12-31
Director/Board Member 42 19-11-10
Director/Board Member - 21-12-19
Director/Board Member 24 Nov. 22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 119,565,000 43,283,695 ( 36.20 %) 0 36.20 %

Shareholders

NameEquities%Valuation
25,285,600 21.15 % 1 498 M ₹
8,695,360 7.272 % 515 M ₹
7,682,000 6.425 % 455 M ₹
Singh Dhananjay Kumar /Estate Of/
5.391 %
6,445,745 5.391 % 382 M ₹
5,138,220 4.297 % 304 M ₹
3,423,312 2.863 % 203 M ₹
3,034,535 2.538 % 180 M ₹
2,937,740 2.457 % 174 M ₹
DSP Asset Managers Pvt. Ltd.
2.417 %
2,890,017 2.417 % 171 M ₹
2,835,342 2.371 % 168 M ₹

Company contact information

Alkem Laboratories Ltd.

Devashish Building, Alkem House Senapati Bapat Marg

400013, Mumbai

+91 22 3982 9999

http://www.alkemlabs.com
address Alkem Laboratories Limited(ALKEM)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Generic
Pharmaceuticals: Major
S&B Pharma LLC
The Pharma Network LLP

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
4,721 INR
Average target price
5,184 INR
Spread / Average Target
+9.81%
Consensus
  1. Stock Market
  2. Equities
  3. ALKEM Stock
  4. Company Alkem Laboratories Limited